The Ins and Outs of Tumor Testing In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates. by Kate Yandell From the Editor-in-Chief DNA Profiling Moves From Forensics to Diagnostics DNA profiling technologies are providing new ways to detect and monitor cancer. by William G. Nelson, MD, PhD Is 3-D Mammography Better? A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography. by Marci A. Landsmann Cancer Control in the Community Successful public health initiatives to prevent, detect and treat cancer require widespread community participation. by Marci A. Landsmann Forward Look Breast Density Matters Breast cancer risk factor may be overlooked. by Kendall K. Morgan A Focus on Pediatric Cancer Screening The AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes. by Garrett M. Brodeur Revised Prostate Cancer Screening Guidelines Proposed The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening. Screening Gets Personal Conflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms? by Kate Yandell Forward Look All About Overdiagnosis Q&A with epidemiologist Pam Marcus on why cancer screening can have risks. by Sue Rochman Forward Look Do You Know BRCA? Learn more about educational efforts to increase understanding of the 'breast cancer' gene. by Sue Rochman next Cancer Talk Will Right to Try Increase Access to Experimental Treatments? The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients. by Marci A. Landsmann What Older Patients Value Many older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible. by Cheryl Platzman Weinstock Omitting Obesity Many cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research. by Cici Zhang Questioning an Entrenched Practice To defend against bacterial infections, cancer patients are often put on a neutropenic diet—which bars fresh fruits and vegetables, among other things. Research indicates that following this diet is unnecessary. by Brad Jones More Posts